SCHEMBL6287963

SCHEMBL6287963

CC(C)c1cnc(NC(=O)N[C@H](C)C(=O)NCc2ccccc2)s1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 8/20 0.61
CCNE1 P24864 6/20 0.61
CDK5 Q00535 6/20 0.61
CCNT1 O60563 1/20 0.61
ALDH1A1 P00352 1/20 0.61
CDK1 P06493 1/20 0.61
CDK4 P11802 1/20 0.61
CCNB1 P14635 1/20 0.61
CCNA2 P20248 1/20 0.61
CCND1 P24385 1/20 0.61
CDK7 P50613 1/20 0.61
CDK9 P50750 1/20 0.61
CCNH P51946 1/20 0.61
MNAT1 P51948 1/20 0.61
CDK5R1 Q15078 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
ATG4B Q9Y4P1 3/20 0.49
GSK3A P49840 1/20 0.49
GSK3B P49841 1/20 0.49
DYRK1A Q13627 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6288010 0.88 CDK2 (0.69) CDK2CCNE1CDK5CCNT1ALDH1A1
SCHEMBL6283555 0.78 ATG4B (0.62) CDK2CCNE1CDK5CCNT1ALDH1A1
SCHEMBL6286739 0.77 ATG4B (0.64) CDK2CCNE1CDK5CCNT1ALDH1A1
SCHEMBL6286130 0.77 ATG4B (0.63) CDK2CCNE1CDK5CCNT1ALDH1A1
SCHEMBL6285422 0.77 ATG4B (0.63) CDK2CCNE1CDK5CCNT1ALDH1A1
SCHEMBL1535301 0.76 CCNE1 (1.00) CDK2CCNE1CDK5CCNT1ALDH1A1
SCHEMBL6285981 0.76 CDK2 (0.64) CDK2CCNE1CDK5CCNT1ALDH1A1
SCHEMBL6278561 0.76 CDK2 (0.64) CDK2CCNE1CDK5CCNT1ALDH1A1
SCHEMBL6284074 0.76 CDK2 (1.00) CDK2CCNE1CDK5CCNT1ALDH1A1
SCHEMBL6287944 0.76 ATG4B (0.66) CDK2CCNE1CDK5CCNT1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6863647-B2 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents PHARMACIA & UPJOHN S.P.A. (IT) 2005-03-08 US disclosed